Understand your drug candidates’ potential pharmacological profile using a suite of validated in vivo models. Partner with us to select the most appropriate platform, study design, and screening method tailored to each of your individual drug candidates and research question. Each of our models are supported by a range of translational tools including biomarker, in vitro / ex vivo assays, and in silico modelling to optimize lead candidates.
Patient-Derived Xenograft Models
Leverage our unrivalled collection of PDX models, derived directly from patient tumors to reflect the heterogeneity and diversity of the human patient population